V
Virax Biolabs Group Ltd
NASDAQ:VRAX
Virax Biolabs Group Ltd
NASDAQ:VRAX
Price:
0.2125
USD
7.27%
Market Closed
Market Cap:
$4.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Virax Biolabs Group Ltd
NASDAQ:VRAX
|
UK |
|
Advantest Corp
OTC:ATEYY
|
JP |
Wall St Price Targets
VRAX Price Targets Summary
Virax Biolabs Group Ltd
Virax Biolabs Group Ltd
Wall Street analysts forecast VRAX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for VRAX is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.
Lowest Forecast
Price Target
1.01
USD
375% Upside
Average Forecast
Price Target
1.02
USD
380% Upside
Highest Forecast
Price Target
1.05
USD
394% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VRAX's stock price target?
Price Target
1.02
USD
1.02
USD
According to Wall Street analysts, the average 1-year price target for VRAX is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.
What is the Revenue forecast for Virax Biolabs Group Ltd?
Projected CAGR
2 445%
2 445%
Over the last 4 years, the compound annual growth rate for Revenue has been -52%. The projected CAGR for the next 2 years is 2 445%.
